FDA announced the approval of an epinephrine injector product called Symjepi

0

FDA Approves New Epinephrine Injector for Anaphylaxis -Symjepi is latest alternative to EpiPen” Medpagetoday (2017).

Medpagetoday report “The FDA announced the approval of an epinephrine injector product called Symjepi, made by Adamis Pharmaceutical Corp. as the latest alternative to Mylan Pharmaceuticals’ EpiPen for the treatment of severe allergic reactions.

The product is a 0.3-mg prefilled syringe for the emergency treatment of allergic reactions, including anaphylaxis, for patients who weigh 30 kg (66 pounds) or more. The agency noted in a press release that the drug is not meant as an alternative to EpiPen Jr, which is intended for patients weighing between 15 kg and 30 kg (or 33 to 66 pounds).”

Full Press Release

Thank you to our partners for supporting IVTEAM

Share.

Comments are closed.

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.